Onyx HealthcareROCO:6569 75 Altman Z-Score is 5.46 as of Jul. 12, 2026, which is 34% below its 10-year median of 8.29. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 77.73% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 5.46 is strong.
Onyx Healthcare has a Altman Z-Score of 5.46, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Onyx Healthcare's Altman Z-Score or its related term are showing as below:
ROCO:6569'
s Altman Z-Score Range Over the Past 10 Years
Min: 4.14 Med: 8.29 Max: 10.39
Current: 5.46
During the past 13 years, Onyx Healthcare's highest Altman Z-Score was 10.39. The lowest was 4.14. And the median was 8.29.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Onyx Healthcare Altman Z-Score Related Terms
Onyx Healthcare Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, TEM: Altman Z-Score Comparison
For the Health Information Services subindustry, Onyx Healthcare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Onyx Healthcare's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.2088
+
1.4
*
0.0926
+
3.3
*
0.0588
+
0.6
*
7.1299
+
1.0
*
0.6098
=
5.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Onyx Healthcare (ROCO:6569) has a Altman Z-Score of 5.46 as of Jul. 12, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Onyx Healthcare and its competitors. This is 34% below median its historical median of 8.29. Over the past decade, Onyx Healthcare's Altman Z-Score has ranged from 4.14 to 10.39. According to the industry distribution chart, Onyx Healthcare ranks #147 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is Onyx Healthcare's Altman Z-Score too high?
Onyx Healthcare's current Altman Z-Score of 5.46 is 34% below median its 10-year median of 8.29. Over the past 10 years, this metric has ranged from a low of 4.14 to a high of 10.39. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. Onyx Healthcare's value of 5.46 is 122.9% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #147 out of 660 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Altman Z-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #147 out of 660 companies for Altman Z-Score. This places Onyx Healthcare in the top 22% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.45. Onyx Healthcare's value of 5.46 is 122.9% above this benchmark. Historically, Onyx Healthcare's own Altman Z-Score has ranged from 4.14 to 10.39 over the past decade. While the company's 10-year median is 8.29 vs. the industry median of 2.45, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Altman Z-Score of 5.46 is 122.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Altman Z-Score is 5.46, which is 34% below median its own 10-year median of 8.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Altman Z-Score is 5.46, which is 34% below median its 10-year median of 8.29 and 122.9% above the Healthcare Providers & Services industry median of 2.45. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Altman Z-Score is 5.46 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
Altman Z-Score: 5.46 (34% below median its 10-year median of 8.29)
GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
Industry Position: 122.9% above the Healthcare Providers & Services median (#147 of 660)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
